Firstly appreciate you engaging with my posts.The comparison between APX and MSB is simply NOT ON. How about we take a look at the 10-15 year returns for other biotech stocks, like CSL, COH, PME, TLX, or even some solid US-based healthcare stocks?
There are some great growth healthcare stocks in the US that have surged 5x to 10x over the years—companies like Axsome Therapeutics, Vertex Pharmaceuticals, Regeneron Pharmaceuticals etc to name a few.
These stocks have shown tremendous growth and long-term value.
The point I was making is all about being a long-term holder and focusing on ROI and MSB has been painful for long-term holders, and they’ve really been let down over time. 10 year RETURN -VE 15 year RETURN -VE.. someone earlier said "MSB is and always was a long term investment where patience and big cahoonas should be rewarded"
While others may discuss empathy, causes, and such, I absolutely respect that. But if that’s your focus, there are plenty of charities to donate to for a great human cause. When it comes to the stock market, it’s all about returns on investment. It's frustrating to see people attacking or labeling those focused on investing as cold-hearted. We all want to make a difference in the world, but when you're in the stock market, it’s about returns for your investment. It’s not about being insensitive—it’s about managing risk, reward, and positioning yourself for long-term growth.
hate when people blindly judge you that i have a family member who suffers from blah blah and calling u inhumane. just plain stupidity
- Forums
- ASX - By Stock
- MSB
- Ann: Ryoncil Is Now Available For Purchase In The United States
MSB
mesoblast limited
Add to My Watchlist
1.85%
!
$1.65

Ann: Ryoncil Is Now Available For Purchase In The United States, page-145
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.65 |
Change
0.030(1.85%) |
Mkt cap ! $2.108B |
Open | High | Low | Value | Volume |
$1.64 | $1.67 | $1.63 | $4.884M | 2.962M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 10583 | $1.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.66 | 16415 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 10583 | 1.650 |
2 | 23000 | 1.645 |
4 | 27999 | 1.640 |
1 | 876 | 1.635 |
4 | 18446 | 1.630 |
Price($) | Vol. | No. |
---|---|---|
1.660 | 10415 | 2 |
1.665 | 30000 | 2 |
1.670 | 16598 | 2 |
1.675 | 4000 | 1 |
1.680 | 17509 | 4 |
Last trade - 16.12pm 27/06/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online